Patents-Review.com
ClassID:

97119 ⎘

C07K16/1081 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus

Sub-classes:
Recent Application in this class:
#1
20260055145
2026-02-26

ANTI-DENGUE VACCINES AND ANTIBODIES

 #2
20260008824
2026-01-08

PLANT-PRODUCED mABs AGAINST CHIKUNGUNYA VIRUS WITH ENHANCED EFFECTOR FUNCTION AND EFFICACY

 #3
20260001941
2026-01-01

ANTI-DENGUE VIRUS ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE

 #4
20260001940
2026-01-01

ANTI-CHIKV ANTIBODIES AND USES THEREOF

 #5
20250296982
2025-09-25

ENGINEERED POLYPEPTIDES AND USES THEREOF

 #6
20250277015
2025-09-04

HUMAN MONOCLONAL ANTIBODIES TO EASTERN EQUINE ENCEPHALITIS VIRUS AND USES THEREFOR

 #7
20250276052
2025-09-04

RECONSTITUTION AND USES OF FLAVIVlRUS EPITOPES

 #8
20250189525
2025-06-12

PREPARATION METHOD AND APPLICATION OF NANOBODY TARGETING DENGUE VIRUS NS1 PROTEIN

 #9
20250155432
2025-05-15

NANOBODY CLASSICAL SWINE FEVER VIRUS (CSFV)-E0-Nb1 AGAINST CSFV E0 PROTEIN, GENE ENCODING THE SAME AND USE THEREOF

 #10
20250011401
2025-01-09

OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS

 #11
20250002566
2025-01-02

POLYNUCLEOTIDE, EXPRESSION CASSETTE, VECTOR, HOST CELL, POLYPEPTIDE, PHARMACEUTICAL COMPOSITION, USE OF A POLYPEPTIDE, METHOD FOR PRODUCING A POLYPEPTIDE, AND METHOD FOR PREVENTING OR TREATING INFECTIONS CAUSED BY FLAVIVIRUSES

 #12
20240425569
2024-12-26

ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF

 #13
20240376184
2024-11-14

IgA MONOCLONAL ANTIBODIES FOR TREATING FLAVIVIRUS INFECTION

 #14
20240369556
2024-11-07

ISOLATED MONOCLONAL ANTIBODY, ISOLATED ANTIGEN BINDING FRAGMENT THEREOF, COMPOSITION, METHOD OF ELICITING IMMUNE RESPONSE AGAINST ANTIGENIC EPITOPE OF FLAVIVIRUS IN SUBJECT, METHOD FOR DETECTING FLAVIVIRUS, POLYPEPTIDE, AND ANTIBODY-CELL CONJUGATION

 #15
20240352097
2024-10-24

NEUTRALIZING ANTIBODY FOR FLAVIVIRUSES AND PRODUCTION METHOD THEREOF

 #16
20240309073
2024-09-19

METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

 #17
20240254207
2024-08-01

MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF

 #18
20240226291
2024-07-11

COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS

 #19
20240190948
2024-06-13

ANTI-DENGUE VIRUS ANTIBODIES HAVING CROSS-REACTIVITY TO ZIKA VIRUS AND METHODS OF USE

 #20
20240131154
2024-04-25

COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS

 #21
20240018219
2024-01-18

Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

 #22
20240002480
2024-01-04

BROADLY NEUTRALIZING ANTIBODIES TO TICK-BORNE ENCEPHALITIS AND RELATED VIRUSES

 #23
20240002479
2024-01-04

SINGLE-CHAIN ANTIBODY AGAINST FLAVIVIRUS NS1 PROTEIN

 #24
20230287598
2023-09-14

HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS

 #25
20230265171
2023-08-24

RECOMBINANT POLYCLONAL PROTEINS TARGETING ZIKA AND METHODS OF USE THEREOF

 #26
20230235092
2023-07-27

ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

 #27
20230181714
2023-06-15

HUMAN MONOCLONAL ANTIBODIES TO VENEZUELAN EQUINE ENCEPHALITIS VIRUS AND USES THEREFOR

 #28
20230086835
2023-03-23

FLAVIVIRUS CROSS NEUTRALIZING ANTIBODY AND PHARMACEUTICAL COMPOSITION

 #29
20230078330
2023-03-16

HUMAN ANTI-DENGUE ANTIBODIES AND METHODS OF USE THEREFOR

 #30
20230072640
2023-03-09

Human monoclonal antibodies against yellow fever virus and uses therefor

 #31
20230050657
2023-02-16

Single Domain Antibodies that Bind and Neutralize Venezuelan Equine Encephalitis Virus

 #32
20230023093
2023-01-26

DNA ANTIBODY CONSTRUCTS AND METHOD OF USING SAME

 #33
20230020362
2023-01-19

INFECTIOUS DISEASE VACCINES

 #34
20220357312
2022-11-10

METHODS FOR DETERMINING ANTIBODY AFFINITY AND BINDING KINETICS USING VLPS OR LIVE VIRUSES ATTACHED TO BIOSENSORS

 #35
20220332800
2022-10-20

NOVEL ANTI-ZIKA VIRUS ANTIBODIES AND USES THEREOF

 #36
20220306729
2022-09-29

NEUTRALIZING ANTIBODIES THAT BIND TO THE ZIKA VIRUS DOMAIN III ENVELOPE REGION

 #37
20220298211
2022-09-22

PLANT-PRODUCED mABs AGAINST CHIKUNGUNYA VIRUS WITH ENHANCED EFFECTOR FUNCTION AND EFFICACY

 #38
20220275063
2022-09-01

Anti-CHIKV antibodies and uses thereof

 #39
20220265806
2022-08-25

Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same

 #40
20220195394
2022-06-23

THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES

 #41
20220177553
2022-06-09

Antibody molecules to dengue virus and uses thereof

 #42
20220153817
2022-05-19

Systems and Methods for the Production of Human Polyclonal Antibodies

 #43
20220144921
2022-05-12

DENGUE VIRUS NON-STRUCTURAL PROTEIN 1 SPECIFIC BINDING POLYPEPTIDES AND METHODS OF USING THE SAME

 #44
20220127307
2022-04-28

ANTI-DENGUE VACCINES AND ANTIBODIES

 #45
20220112273
2022-04-14

DNA Antibody Constructs And Method Of Using Same

 #46
20220064268
2022-03-03

Recombinant polyclonal proteins targeting Zika and methods of use thereof

 #47
20210395347
2021-12-23

NS1-binding protein

 #48
20210363227
2021-11-25

NOVEL ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF

 #49
20210355198
2021-11-18

Antibodies specifically binding to Zika virus epitopes and uses thereof

 #50
20210355167
2021-11-18

Neutralising antibody against dengue for use in a method of prevention and/or treatment of Zika infection

 #51
20210347864
2021-11-11

Human zika virus antibodies and methods of use therefor

 #52
20210347863
2021-11-11

Nucleic acids encoding single domain antibodies to chikungunya virus

 #53
20210340227
2021-11-04

Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same

 #54
20210332111
2021-10-28

Antibodies to zika virus and methods of use thereof

 #55
20210324054
2021-10-21

Binding protein of NS1 protein

 #56
20210316009
2021-10-14

Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses

 #57
20210301000
2021-09-30

NS1-Binding Protein and Uses Thereof

 #58
20210263031
2021-08-26

Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens

 #59
20210238262
2021-08-05

Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

 #60
20210187093
2021-06-24

Vaccine compositions

 #61
20210139564
2021-05-13

METHODS AND COMPOSITIONS FOR TREATING YELLOW FEVER

 #62
20210115115
2021-04-22

Human West Nile virus antibodies and methods of use therefor

 #63
20210101962
2021-04-08

Mosaic chimeric viral vaccine particle

 #64
20210095008
2021-04-01

Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of use

 #65
20210054055
2021-02-25

HIGHLY SPECIFIC ZIKA NEUTRALIZING HUMAN ANTIBODIES

 #66
20210017256
2021-01-21

Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use

 #67
20210009663
2021-01-14

ANTIBODIES THAT BIND ZIKA VIRUS ENVELOPE PROTEIN AND USES THEREOF

 #68
20210009662
2021-01-14

Antibody-mediated neutralization of chikungunya virus

 #69
20200399349
2020-12-24

Broad-spectrum monoclonal antibodies against chikungunya virus E1 structural protein

 #70
20200390879
2020-12-17

Human Japanese Encephalitis Virus antibodies and methods of use therefor

 #71
20200369748
2020-11-26

Polynucleotides encoding anti-chikungunya virus antibodies

 #72
20200368344
2020-11-26

CHIKV RNA vaccines

 #73
20200368343
2020-11-26

ZIKA VIRUS MRNA VACCINES

 #74
20200363415
2020-11-19

Anti-dengue virus NS1 protein monoclonal antibodies

 #75
20200339669
2020-10-29

BINDING MOLECULES TARGETING PATHOGENS

 #76
20200317755
2020-10-08

Multispecific antibodies specifically binding to Zika virus epitopes

 #77
20200277359
2020-09-03

Antibody-mediated neutralization of chikungunya virus

 #78
20200277358
2020-09-03

ENGINEERED POLYPEPTIDES AND USES THEREOF

 #79
20200264176
2020-08-20

ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF

 #80
20200261564
2020-08-20

Measurement of afucosylated IgG Fc glycans and related vaccination methods

 #81
20200240982
2020-07-30

Use of Specific Covalent Bonding for Oriented Immobilization of Recombinant Antibody Fragments

 #82
20200239599
2020-07-30

Humanized antibodies with ultralong complementary determining regions

 #83
20200237895
2020-07-30

Mayaro virus consensus antigens, DNA antibody constructs for use against Mayaro virus, and combinations thereof

 #84
20200230227
2020-07-23

Recombinant antigen derived from Zika virus E protein and use thereof

 #85
20200223944
2020-07-16

HUMANIZED ANTIBODIES

 #86
20200207841
2020-07-02

Full spectrum anti-dengue antibody

 #87
20200147199
2020-05-14

Neutralizing antibodies that bind to the zika virus domain III envelope region

 #88
20200131251
2020-04-30

IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

 #89
20200087383
2020-03-19

Anti-dengue virus antibody, pharmaceutical composition comprising the same, and uses thereof

 #90
20200080060
2020-03-12

Three-dimensional printed organs, devices, and matrices

 #91
20200079838
2020-03-12

Mosaic chimeric viral vaccine particle

 #92
20200062831
2020-02-27

Anti-Zika virus antibodies and methods of use

 #93
20200062830
2020-02-27

Flavivirus neutralizing antibodies and methods of use thereof

 #94
20200031875
2020-01-30

Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses

 #95
20200024331
2020-01-23

Single domain antibodies to Chikungunya virus

 #96
20190375826
2019-12-12

Anti-dengue virus antibodies and applications thereof

 #97
20190359694
2019-11-28

Serological assay for the detection of zika virus-specific antibodies utilizing overlapping peptides comprising an NS2B epitope

 #98
20190358313
2019-11-28

NEW FLAVIVIRUS VACCINE

 #99
20190324040
2019-10-24

ZIKA VIRUS ANTIBODIES

 #100
20190315840
2019-10-17

Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

 #101
20190315839
2019-10-17

Dengue virus-like particle, antibody against dengue virus, and composition comprising the same

 #102
20190315838
2019-10-17

Antibodies that bind zika virus envelope protein and uses thereof

 #103
20190276520
2019-09-12

Human Zika virus antibodies and methods of use therefor

 #104
20190256582
2019-08-22

Antibodies specifically binding to zika virus epitopes and uses thereof

 #105
20190256560
2019-08-22

Neutralising antibody against dengue for use in a method of prevention and/or treatment of zika infection

 #106
20190248875
2019-08-15

Zika virus vaccine composition and application thereof

 #107
20190240328
2019-08-08

NOVEL HUMANIZED ANTI-EBOLA ANTIBODIES USEFUL IN PREVENTING EBOLA INFECTIONS

 #108
20190233813
2019-08-01

Method of discovering specific functional antibodies

 #109
20190233505
2019-08-01

METHODS OF TREATING OR PREVENTING ZIKA VIRUS INFECTION

 #110
20190225654
2019-07-25

Methods and compositions for dengue virus vaccines

 #111
20190218277
2019-07-18

Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

 #112
20190211065
2019-07-11

HIGH POTENCY IMMUNOGENIC COMPOSITIONS

 #113
20190209674
2019-07-11

DNA antibody constructs encoding anti-ZIKV envelope antibodies

 #114
20190170751
2019-06-06

Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens

 #115
20190153074
2019-05-23

Antibody molecules to dengue virus and uses thereof

 #116
20190091322
2019-03-28

DNA ANTIBODY CONSTRUCTS AND METHOD OF USING SAME

 #117
20190085058
2019-03-21

DNA antibody constructs and method of using same

 #118
20190062410
2019-02-28

NON-HUMAN ANIMALS HAVING A MUTANT KYNURENINASE GENE

 #119
20190060438
2019-02-28

Infectious disease vaccines

 #120
20190031722
2019-01-31

Modified Zika virus NS1 protein with reduced cross-reactive immunogenicity

 #121
20190010463
2019-01-10

Methods for printing organs and organoids

 #122
20180371063
2018-12-27

Therapy and prophylaxis of infectious disease caused by zika virus

 #123
20180346554
2018-12-06

DNA ANTIBODY CONSTRUCTS AND METHOD OF USING SAME

 #124
20180344839
2018-12-06

CHIKV RNA vaccines

 #125
20180312549
2018-11-01

High potency immunogenic zika virus compositions

 #126
20180311326
2018-11-01

IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES

 #127
20180280496
2018-10-04

Zika RNA vaccines

 #128
20180251531
2018-09-06

Flavivirus neutralizing antibodies and methods of use thereof

 #129
20180246101
2018-08-30

ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF

 #130
20180237504
2018-08-23

Full spectrum anti-dengue antibody

 #131
20180222999
2018-08-09

Humanized antibodies

 #132
20180127487
2018-05-10

Anti-CHIKV monoclonal antibodies directed against the E2 structural protein

 #133
20180105587
2018-04-19

BINDING MOLECULES TARGETING PATHOGENS

 #134
20180105583
2018-04-19

Antibodies that bind Zika virus envelope protein and uses thereof

 #135
20180094046
2018-04-05

Mosaic chimeric viral vaccine particle

 #136
20180079802
2018-03-22

Antibody-mediated neutralization of Chikungunya virus

 #137
20180072798
2018-03-15

Serotype cross-reactive, dengue neutralizing antibody and uses thereof

 #138
20180037634
2018-02-08

Engineered polypeptides and uses thereof

 #139
20180037611
2018-02-08

Anti-dengue vaccines and antibodies

 #140
20180030097
2018-02-01

Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses

 #141
20180016324
2018-01-18

Anti-Zika virus antibodies and methods of use

 #142
20170275639
2017-09-28

Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection

 #143
20170266282
2017-09-21

DNA antibody constructs and method of using same

 #144
20170247436
2017-08-31

NON-HUMAN ANIMALS HAVING A MUTANT KYNURENINASE GENE

 #145
20170233459
2017-08-17

Systems and methods for the production of human polyclonal antibodies

 #146
20170151321
2017-06-01

CHIMERIC PESTIVIRUSES

 #147
20170089898
2017-03-30

Anti-dengue virus antibodies and uses thereof

 #148
20170081394
2017-03-23

Molecular imprinting of West Nile antibodies with physiological pH matching

 #149
20170067895
2017-03-09

Methods and materials for the detection of dengue virus infection

 #150
20170035874
2017-02-09

ENVELOPED VIRUS VACCINE AND METHOD FOR PRODUCTION

 #151
20170029489
2017-02-02

Human monoclonal antibody with specificity for dengue virus serotype 1 E protein and uses thereof

 #152
20170015733
2017-01-19

Binding molecules against Chikungunya virus and uses thereof

 #153
20170014502
2017-01-19

Vaccine compositions

 #154
20170000849
2017-01-05

CD300A RECEPTORS AS VIRUS ENTRY COFACTORS

 #155
20160311891
2016-10-27

DNA antibody constructs and method of using same

 #156
20160257719
2016-09-08

Methods and compositions for dengue virus vaccines

 #157
20160251413
2016-09-01

Antibody molecules to dengue virus and uses thereof

 #158
20160199478
2016-07-14

ENVELOPED VIRUS VACCINE AND METHOD FOR PRODUCTION

 #159
20160159928
2016-06-09

Humanized antibodies with ultralong complementary determining regions

 #160
20160145323
2016-05-26

Antibodies against chikungunya virus and uses thereof

 #161
20160137722
2016-05-19

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

 #162
20160046697
2016-02-18

Antibody molecules to dengue virus and uses thereof

 #163
20160024189
2016-01-28

Flavivirus neutralizing antibodies and methods of use thereof

 #164
20150368321
2015-12-24

Full spectrum anti-dengue antibody

 #165
20150284448
2015-10-08

Compositions and methods for generating a synthetic antibody

 #166
20150225474
2015-08-13

Antibody molecules to dengue virus and uses thereof

 #167
20150218255
2015-08-06

Cross-reactive antibodies against dengue virus and uses thereof

 #168
20150203586
2015-07-23

Macromolecular compositions that cross the blood-brain barrier and methods of use thereof

 #169
20150182636
2015-07-02

Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

 #170
20150175683
2015-06-25

BINDING MOLECULES TARGETING PATHOGENS

 #171
20150111197
2015-04-23

Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof

 #172
20150086978
2015-03-26

Methods and materials for the detection of dengue virus infection

 #173
20150086973
2015-03-26

Monoclonal antibody against duck tembusu virus, hybridoma cell line and application thereof

 #174
20150011431
2015-01-08

HUMANIZED ANTIBODIES

 #175
20140349321
2014-11-27

BINDING MOLECULES AGAINST DENGUE VIRUS AND USES THEREOF

 #176
20140288273
2014-09-25

Macromolecular compositions that cross the blood-brain barrier and methods of use thereof

 #177
20140248306
2014-09-04

Lentiviral gene transfer vectors and their medicinal applications

 #178
20140112927
2014-04-24

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

 #179
20140056913
2014-02-27

Anti-dengue virus antibodies and uses thereof

 #180
20140050754
2014-02-20

IMMUNOGENIC CHIKUNGUNYA VIRUS PEPTIDES

 #181
20130344058
2013-12-26

MONOCLONAL ANTIBODIES AGAINST DENGUE AND OTHER VIRUSES WITH DELETION IN FC REGION

 #182
20130295090
2013-11-07

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

 #183
20130259871
2013-10-03

Human monoclonal antibody with specificity for Dengue virus serotype 1 E protein and uses thereof

 #184
20130189279
2013-07-25

Binding molecules against Chikungunya virus and uses thereof

 #185
20130164734
2013-06-27

Methods and materials for the detection of dengue virus infection

 #186
20130071418
2013-03-21

Physicochemical (PCP) based consensus sequences and uses thereof

 #187
20120329994
2012-12-27

Production of a monoclonal antibody therapeutic against west nile virus in plants

 #188
20120315296
2012-12-13

Lentiviral gene transfer vectors and their medicinal applications

 #189
20120244150
2012-09-27

ANTI-VEEV HUMANIZED ANTIBODY

 #190
20120178909
2012-07-12

Screening strategies for the identification of binders

 #191
20120093862
2012-04-19

Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

 #192
20120076794
2012-03-29

Host cell specific binding molecules capable of neutralizing viruses and uses thereof

 #193
20120076758
2012-03-29

ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF

 #194
20120070454
2012-03-22

Dengue vaccine, pharmaceutical composition comprising the same, nucleotide sequence and antibody composition

 #195
20120070429
2012-03-22

HUMANIZED ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF

 #196
20120020957
2012-01-26

Dengue virus neutralizing antibodies and use thereof

 #197
20120014945
2012-01-19

Anti-dengue virus antibodies

 #198
20120009216
2012-01-12

Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form

 #199
20120009189
2012-01-12

Antibody composition with altered Fab sialylation

 #200
20110218157
2011-09-08

Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome

 #201
20110177023
2011-07-21

Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

 #202
20110150904
2011-06-23

Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases

 #203
20110143333
2011-06-16

Anti-chikungunya monoclonal antibodies and uses thereof

 #204
20110117118
2011-05-19

Molecules, compositions, methods and kits for applications associated with flaviviruses

 #205
20110033462
2011-02-10

Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use

 #206
20110008256
2011-01-13

Monoclonal antibodies that bind or neutralize dengue virus

 #207
20100303801
2010-12-02

Host cell specific binding molecules capable of neutralizing viruses and uses thereof

 #208
20100297168
2010-11-25

Lentiviral gene transfer vectors and their medicinal applications

 #209
20100290985
2010-11-18

Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions

 #210
20100247549
2010-09-30

Monoclonal antibodies against dengue and other viruses with deletion in Fc region

 #211
20100247532
2010-09-30

Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies

 #212
20100190147
2010-07-29

Method of determining immune enhancement of virus infectivity using Fc receptor-transfected cell lines

 #213
20100150912
2010-06-17

BLOCKING INTERACTION BETWEEN PATHOGEN FACTORS AND FACTOR H TO INHIBIT HEMORRHAGIC SYNDROMES

 #214
20100143376
2010-06-10

Antibodies Specific for Rubella Virus

 #215
20100136055
2010-06-03

Chimeric pestiviruses

 #216
20100055105
2010-03-04

Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof

 #217
20100047282
2010-02-25

Method of accelerated vaccination against Ebola viruses

 #218
20100040643
2010-02-18

Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

 #219
20100003273
2010-01-07

Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

 #220
20090324593
2009-12-31

Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof

 #221
20090311246
2009-12-17

Method of Enhancing Remyelination in Demyelinating Diseases of the Central Nervous System

 #222
20090304679
2009-12-10

Antibodies as T cell receptor mimics, methods of production and uses thereof

 #223
20090304633
2009-12-10

Chimeric vaccine antigens against classical swine fever virus

 #224
20090258011
2009-10-15

Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof

 #225
20090226478
2009-09-10

Early detection of flaviviruses using the NS1 glycoprotein

 #226
20090196874
2009-08-06

Methods for detecting enveloped virus infections by measuring cell surface TSG101

 #227
20090181036
2009-07-16

Pharmaceutical Compositions and Articles of Manufacture Useful in Reversal of a Clinical Episode of an Incurable Disease and Methods of Use Thereof

 #228
20090130123
2009-05-21

Antibodies to west nile virus polypeptides

 #229
20090117105
2009-05-07

HUMANIZED ANTI-VENEZUELAN EQUINE ENCEPHALITIS VIRUS RECOMBINANT ANTIBODY

 #230
20090092622
2009-04-09

MOLECULES, COMPOSITIONS, METHODS AND KITS FOR APPLICATIONS ASSOCIATED WITH FLAVIVIRUSES

 #231
20090087438
2009-04-02

Anti-TSG101 antibodies and their uses for treatment of viral infections

 #232
20090068213
2009-03-12

Early detection of flaviviruses using the NS1 glycoprotein

 #233
20090042182
2009-02-12

Detection of bovine viral diarrhea virus in tissue samples

 #234
20090041780
2009-02-12

Medicinal concentrate of arbovirus specific immunoglobulins and F(ab)'2 and/or Fab fragments

 #235
20080279863
2008-11-13

Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases

 #236
20080241186
2008-10-02

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

 #237
20080219969
2008-09-11

Concentrate of Chikungunya-Specific Immunoglobulins as a Medicinal Product

 #238
20080171055
2008-07-17

Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions

 #239
20080170994
2008-07-17

Fusion antibodies that cross the blood-brain barrier in both directions

 #240
20080152645
2008-06-26

Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns

 #241
20070166701
2007-07-19

Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence

 #242
20070166329
2007-07-19

Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

 #243
20070141617
2007-06-21

Enveloped virus vaccine and method for production

 #244
20070134256
2007-06-14

Monoclonal antibodies that bind or neutralize dengue virus

 #245
20070122801
2007-05-31

Binding molecules capable of neutralizing West Nile virus and uses thereof

 #246
20070065452
2007-03-22

THERAPEUTIC ANTIBODIES FOR TREATMENT AND PROPHYLAXIS OF TRANSMITTABLE VIRAL DISEASES

 #247
20070042359
2007-02-22

Binding molecules capable of neutralizing west nile virus and uses thereof

 #248
20070014789
2007-01-18

Humanized antibody conjugates and related methods, assays, reagents, and kits

 #249
20060269572
2006-11-30

Method of accelerated vaccination against Ebola viruses

 #250
20060269571
2006-11-30

Equine West Nile virus immunotherapy

 #251
20060188894
2006-08-24

Method for screening compounds against by using persistent virus-infected cell system

 #252
20060115837
2006-06-01

Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody

 #253
20060067940
2006-03-30

Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof

 #254
20060057149
2006-03-16

Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof

 #255
20060024766
2006-02-02

Bifunctional molecules

 #256
20050287170
2005-12-29

Subunit vaccine against West Nile viral infection

 #257
20050221284
2005-10-06

Heteropolymer complexes and methods for their use

 #258
20050186562
2005-08-25

Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form

 #259
20050163804
2005-07-28

Nucleic acids encoding chimeric immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence

 #260
20050118569
2005-06-02

Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to Venezuelan equine encephalitis virus

 #261
18955940
2025-06-10

Preparation method and application of nanobody targeting dengue virus NS1 protein